Skip to main content

AADIL DIWAN AND SAHIL DIWAN, CO-FOUNDERS

SAFKAN HEALTH'S STORY

Bringing ear care into the 21st century

More than 35 million Americans suffer from impacted earwax, the leading cause of conductive hearing loss. That’s one in 10 children, one in 20 adults, and more than one in three seniors. For 200 years, the medical standard of care has been the ear-and-bladder syringe, a medieval-looking device that squirts water into ear canals.

No more. Medical device startup SafKan Health developed the world’s first automated ear cleaning device — the FDA-cleared OtoSet® Ear Cleaning System. OtoSet brings ear care into the 21st century with a novel system of irrigation and micro-suction technology, all built into an automated and wearable device resembling a familiar and sleek pair of headphones.

OtoSet simplifies earwax removal for clinicians, reducing the time required from 20 minutes to less than five, and offers patients a safe, effective, and mess-free procedure. OtoSet’s cleaning cycle directs liquid from solution containers through disposable ear tips and toward the walls of the ear canals to break down earwax. Continuous micro-suction draws that earwax and liquid back through the ear tips and into disposable waste containers. All sanitary, all simple.

Unorthodox ventures’ impact

We help attention-getting products garner just that. Our experienced marketing team helped SafKan Health land more than 40 articles by publications, including the Daily Mail, Fast Company, Gizmodo, Scripps News and The Sun.

40+

articles

published
Drafted

winning

award applications

Sahil Diwan, Co-Founder & CEO

SafKan Health in the Media

Brand Recognition

Hearing Technology Innovator Awards – 2023 Winner

Hearing Technology Innovator Awards – 2021 Winner

Protolabs Cool Idea! Award – 2019 Honoree

LET’S PARTNER UP

Every year, American entrepreneurs start more than half a million companies. More than 90% of them will fail, with only 200 ever passing $100 million in revenue. At Unorthodox Ventures, we know how to reach $300 million. Jump in with us.